HeimBiotek Develops miRNA-Based Prognostic Diagnostic Kit for Colorectal Cancer
HeimBiotek has announced its collaboration with Sino MD Gene to develop a miRNA-based prognostic diagnostic kit for colorectal cancer. Earlier this year, HeimBiotek successfully developed a miRNA-based diagnostic kit for the BK virus, which was validated through blind tests with Sino MD Gene. They plan to complete the colorectal cancer diagnostic kit by November and will test it on patients in China.
HeimBiotek emphasizes the importance of miRNA analysis technology in providing stable and accurate prognostic diagnostics. They are working with professors from prominent medical institutions for research and development. HeimBiotek aims to enter the Chinese colorectal cancer diagnostic market upon successful validation of the kit.
Additionally, HeimBiotek has developed a miRNA research kit using SBDE™ PCR technology and is one of the few companies globally to enter the miRNA detection and analysis market.
This content is partially excerpted from a news article.